sanguinarine has been researched along with cycloheximide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Buja, LM; Hallock, S; Liepins, A; Tang, SC; Trump, BF; Weerasinghe, P | 1 |
2 other study(ies) available for sanguinarine and cycloheximide
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Aurintricarboxylic acid inhibits protein synthesis independent, sanguinarine-induced apoptosis and oncosis.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Aurintricarboxylic Acid; Benzophenanthridines; Cell Line, Tumor; Cell Transformation, Neoplastic; Cycloheximide; Deoxyribonuclease I; Dose-Response Relationship, Drug; Humans; Isoquinolines; Leukemia, Erythroblastic, Acute; Protein Biosynthesis; Protein Synthesis Inhibitors | 2007 |